Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer

Published:2015-05-07 Issue:5 Volume:10 Page:e0101019
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Ze,Liu Xue-Wei,Chi Zhao-Cheng,Sun Bao-Sheng,Cheng Ying,Cheng Long-Wei

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. Dietary factors and risk of colon cancer in Shanghai, China;BC Chiu;Cancer Epidemiol Biomarkers Prev,2003

2. Incidence of colorectal cancer in Guangzhou City from 2000 to 2002;KJ Cao;Ai Zheng,2009

3. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project;P Piedbois;J Clin Oncol,1992

4. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment;A Grothey;J Clin Oncol,2004

5. KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies;D Soulieres;Curr Oncol,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Combination Therapy for RAS-related Colorectal Cancer;PROG BIOCHEM BIOPHYS;2023

2. Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer;Cancers;2022-11-29

3. The importance of Ras in drug resistance in cancer;British Journal of Pharmacology;2021-04-06

4. Analyzing Security Protocol Web Implementations Based on Model Extraction With Applied PI Calculus;IEEE Access;2020

5. Sulfur-resistant methanation over MoO3/CeO2–ZrO2 catalyst: Influence of Ce-addition methods;Journal of Energy Chemistry;2019-01